THROMBOSIS AND HEMOSTASIS The polyphosphate – factor XII pathway drives coagulation in prostate cancer-associated thrombosis
暂无分享,去创建一个
Evi X. Stavrou | T. Renné | K. Nickel | G. Sauter | C. Bokemeyer | M. Graefen | N. Mackman | T. Fuchs | G. Ronquist | E. Stavrou | F. Langer | L. Labberton | G. Ronquist | Katrin F Nickel
[1] C. Flowers,et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Evi X. Stavrou,et al. Plasma contact system activation drives anaphylaxis in severe mast cell-mediated allergic reactions. , 2015, The Journal of allergy and clinical immunology.
[3] Evi X. Stavrou,et al. Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor. , 2015, Blood.
[4] G. Raskob,et al. Factor XI antisense oligonucleotide for prevention of venous thrombosis. , 2014, The New England journal of medicine.
[5] J. Biedenkapp,et al. A phase 1 study investigating DX-2930 in healthy subjects. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[6] T. Renné,et al. Factor XII Regulates the Pathological Process of Thrombus Formation on Ruptured Plaques , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[7] B. Monia,et al. Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits. , 2014, Blood.
[8] T. Renné,et al. Factor XII inhibition reduces thrombus formation in a primate thrombosis model. , 2014, Blood.
[9] Michael J. Wilson,et al. A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk , 2014, Science Translational Medicine.
[10] G. Ronquist,et al. Role of exosomes in myocardial remodeling. , 2014, Circulation research.
[11] V. Tagalakis,et al. Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants. , 2014, Blood reviews.
[12] J. Andersen,et al. Novel Family of Insect Salivary Inhibitors Blocks Contact Pathway Activation by Binding to Polyphosphate, Heparin, and Dextran Sulfate , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[13] T. Renné,et al. Time-dependent degradation and tissue factor addition mask the ability of platelet polyphosphates in activating factor XII-mediated coagulation. , 2013, Blood.
[14] N. Mackman,et al. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. , 2013, Blood.
[15] A. Walker,et al. Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases. , 2013, European journal of cancer.
[16] Stephanie A. Smith,et al. Inhibition of polyphosphate as a novel strategy for preventing thrombosis and inflammation. , 2012, Blood.
[17] B. Sullenger,et al. Nucleic acid scavengers inhibit thrombosis without increasing bleeding , 2012, Proceedings of the National Academy of Sciences.
[18] T. Renné,et al. Platelet‐ and erythrocyte‐derived microparticles trigger thrombin generation via factor XIIa , 2012, Journal of thrombosis and haemostasis : JTH.
[19] C. Marosi,et al. Microparticle‐associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients , 2012, Journal of thrombosis and haemostasis : JTH.
[20] J. West,et al. Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis , 2012, PLoS medicine.
[21] Stephanie A. Smith,et al. Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation. , 2012, Blood.
[22] A. Walch,et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo , 2012, The Journal of experimental medicine.
[23] G. Ronquist,et al. Prostasomes are mediators of intercellular communication: from basic research to clinical implications , 2012, Journal of internal medicine.
[24] P. Reitsma,et al. The relationship between tissue factor and cancer progression: insights from bench and bedside. , 2012, Blood.
[25] Meredith C Henderson,et al. The Genomic and Proteomic Content of Cancer Cell-Derived Exosomes , 2011, Front. Oncol..
[26] T. Renné,et al. In vivo roles of factor XII. , 2010, Blood.
[27] B. Monia,et al. Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding. , 2011, Blood.
[28] U. Landegren,et al. Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer , 2011, Proceedings of the National Academy of Sciences.
[29] S. Cichon,et al. Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo. , 2011, Immunity.
[30] D. Steinberg,et al. Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis , 2010, Thrombosis and Haemostasis.
[31] P. Sonneveld,et al. Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma , 2010, Thrombosis and Haemostasis.
[32] J. Freyssinet,et al. Circulating procoagulant microparticles in cancer patients , 2011, Annals of Hematology.
[33] James H Morrissey,et al. Polyphosphate exerts differential effects on blood clotting, depending on polymer size. , 2010, Blood.
[34] T. Renné,et al. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. , 2010, Blood.
[35] N. Mackman,et al. Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism. , 2010, Thrombosis research.
[36] Zhongping Cheng,et al. The interaction of coagulation factor XII and monocyte/macrophages mediating peritoneal metastasis of epithelial ovarian cancer. , 2010, Gynecologic oncology.
[37] Lijuan Zhang,et al. Glycosaminoglycans and activated contact system in cancer patient plasmas. , 2010, Progress in molecular biology and translational science.
[38] T. Renné,et al. Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo , 2009, Cell.
[39] J. Blanquer,et al. Pulmonary tumor embolism as an initial manifestation of pancreatic adenocarcinoma. , 2009, Respiratory care.
[40] D. Neuberg,et al. Tumor-Derived Tissue FactorBearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy , 2009, Clinical Cancer Research.
[41] D. Lombardo,et al. Cancer cell–derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo , 2009, The Journal of experimental medicine.
[42] R. Bertina,et al. Microparticle‐associated tissue factor activity in cancer patients with and without thrombosis , 2009, Journal of thrombosis and haemostasis : JTH.
[43] C. Bokemeyer,et al. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer , 2009, Thrombosis and Haemostasis.
[44] A. Gruber,et al. Factor XI contributes to thrombin generation in the absence of factor XII. , 2008, Blood.
[45] A. Kakkar. Venous thromboembolism prophylaxis and treatment in patients with cancer. , 2008, Clinical advances in hematology & oncology : H&O.
[46] M. Stefanoni,et al. Coagulation factor levels in non-metastatic colorectal cancer patients. , 2008, The International journal of biological markers.
[47] James H Morrissey,et al. Sensitive fluorescence detection of polyphosphate in polyacrylamide gels using 4′,6‐diamidino‐2‐phenylindol , 2007, Electrophoresis.
[48] N. Mackman,et al. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[49] A. Khorana,et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy , 2007, Journal of thrombosis and haemostasis : JTH.
[50] K. Ekdahl,et al. Prothrombotic effect of prostasomes of metastatic cell and seminal origin , 2007, The Prostate.
[51] C. Bokemeyer,et al. Plasma tissue factor antigen in localized prostate cancer: Distribution, clinical significance and correlation with haemostatic activation markers , 2007, Thrombosis and Haemostasis.
[52] R. Bertina,et al. Microparticle‐associated tissue factor activity: a link between cancer and thrombosis? , 2007, Journal of thrombosis and haemostasis : JTH.
[53] T. Renné,et al. Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma , 2006, Biological chemistry.
[54] James H Morrissey,et al. Polyphosphate modulates blood coagulation and fibrinolysis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[55] Masanori Saito,et al. Direct Labeling of Polyphosphate at the Ultrastructural Level in Saccharomyces cerevisiae by Using the Affinity of the Polyphosphate Binding Domain of Escherichia coli Exopolyphosphatase , 2005, Applied and Environmental Microbiology.
[56] W. Neugebauer,et al. Hypotensive effects of hemopressin and bradykinin in rabbits, rats and mice A comparative study , 2005, Peptides.
[57] T. Renné,et al. Defective thrombus formation in mice lacking coagulation factor XII , 2005, The Journal of experimental medicine.
[58] F. Marceau,et al. International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences , 2005, Pharmacological Reviews.
[59] M. Hennersdorf,et al. Disseminated Microvascular Pulmonary Tumor Cell Embolism: A Rare Cause of Fulminant Pulmonary Hypertension , 2004, Oncology Research and Treatment.
[60] A. Llorente,et al. Caveolin-1 and MAL are located on prostasomes secreted by the prostate cancer PC-3 cell line , 2004, Journal of Cell Science.
[61] M. Prins,et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. , 2003, The New England journal of medicine.
[62] S. Coughlin,et al. Protection against thrombosis in mice lacking PAR3. , 2002, Blood.
[63] J. Hirsh,et al. A Comparison of the Safety and Efficacy of Oral Antiocoagulation for the Treatment of Venous Thromboembolic Disease in Patients with or without Malignancy , 2000, Thrombosis and Haemostasis.
[64] M Gent,et al. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[65] M. Wick,et al. Tumor-related thrombotic pulmonary microangiopathy: review of pathologic findings and pathophysiologic mechanisms. , 2000, Annals of diagnostic pathology.
[66] L. Melton,et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. , 2000, Archives of internal medicine.
[67] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[68] K. Bernstein,et al. The functional role of angiotensin-converting enzyme as explored by using knockout mice. , 1998, Advances in nephrology from the Necker Hospital.
[69] J. Quintáns,et al. Designer and catalytic antibodies. , 1990, The New England journal of medicine.
[70] A. Aasen,et al. Studies on components of the contact phase system in patients with advanced gastrointestinal cancer , 1990, Cancer.
[71] G. Wikander,et al. Human prostasome membranes exhibit very high cholesterol/phospholipid ratios yielding high molecular ordering. , 1989, Biochimica et biophysica acta.
[72] H. Dvorak,et al. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. , 1983, Cancer research.
[73] J. Griffin,et al. Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI. , 1981, Blood.
[74] J. Caen,et al. Availability of Platelet Factor 3 and Activation of Factor XII in Thrombasthenia , 1965, Nature.
[75] A. Trousseau. Phlegmasia alba dolens. , 1865 .
[76] Medicale Faites,et al. Lectures on Clinical Medicine, Delivered at the Hotel-Dieu of Paris , 1838, Edinburgh Medical and Surgical Journal.